{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:07:47Z","timestamp":1790676467723,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier","isbn-type":[{"value":"9780128014806","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.irn.2015.05.003","type":"book-chapter","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T15:48:57Z","timestamp":1434728937000},"page":"59-86","source":"Crossref","is-referenced-by-count":11,"title":["Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases"],"prefix":"10.1016","author":[{"given":"Annapurna","family":"Nayak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Salt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2006-9309","article-title":"Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders","volume":"9","author":"Abdi","year":"2006","journal-title":"Journal of Alzheimer's Disease"},{"issue":"43","key":"10.1016\/bs.irn.2015.05.003_bb0010","doi-asserted-by":"crossref","first-page":"29427","DOI":"10.1074\/jbc.M109.013193","article-title":"Phosphorylation of threonine 3: Implications for Huntingtin aggregation and neurotoxicity","volume":"284","author":"Aiken","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.irn.2015.05.003_bb0015","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/pr3001546","article-title":"Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains","volume":"11","author":"Andreev","year":"2012","journal-title":"Journal of Proteome Research"},{"issue":"17","key":"10.1016\/bs.irn.2015.05.003_bb0020","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"The Journal of Neuroscience"},{"issue":"12","key":"10.1016\/bs.irn.2015.05.003_bb0025","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/pmic.200400848","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"4","author":"Basso","year":"2004","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10072-003-0106-2","article-title":"Proteome analysis of mesencephalic tissues: Evidence for Parkinson's disease","volume":"24","author":"Basso","year":"2003","journal-title":"Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-5793(91)80737-N","article-title":"Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices","volume":"285","author":"Bauer","year":"1991","journal-title":"FEBS Letters"},{"issue":"16","key":"10.1016\/bs.irn.2015.05.003_bb9070","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1097\/00001756-200011090-00003","article-title":"Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis","volume":"11","author":"Beuche","year":"2000","journal-title":"NeuroReport"},{"issue":"14","key":"10.1016\/bs.irn.2015.05.003_bb0040","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00018-004-4104-1","article-title":"Unraveling the pathogenesis of Parkinson's disease\u2014The contribution of monogenic forms","volume":"61","author":"Bonifati","year":"2004","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mas.21404","article-title":"Redox proteomics: From protein modifications to cellular dysfunction and disease","volume":"33","author":"Butterfield","year":"2014","journal-title":"Mass Spectrometry Reviews"},{"issue":"9","key":"10.1016\/bs.irn.2015.05.003_bb0050","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1212\/WNL.55.9.1396","article-title":"Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Chapman","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2015.05.003_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron","year":"1997","journal-title":"Nature Medicine"},{"issue":"15","key":"10.1016\/bs.irn.2015.05.003_bb0060","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/emboj.2008.133","article-title":"Huntingtin phosphorylation acts as a molecular switch for anterograde\/retrograde transport in neurons","volume":"27","author":"Colin","year":"2008","journal-title":"The EMBO Journal"},{"issue":"2","key":"10.1016\/bs.irn.2015.05.003_bb9030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2007.03.029","article-title":"Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: \u201cRedox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice\u2014a model of familial amyotrophic lateral sclerosis\u201d","volume":"43","author":"Dalle-Donne","year":"2007","journal-title":"Free Radical Biology & Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2015.05.003_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1155\/2005\/848676","article-title":"The use of proteomics in biomarker discovery in neurodegenerative diseases","volume":"21","author":"Davidsson","year":"2005","journal-title":"Disease Markers"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/bs.irn.2015.05.003_bb9010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11068-004-0514-8","article-title":"Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements","volume":"33","author":"DiProspero","year":"2004","journal-title":"Journal of Neurocytology"},{"issue":"5720","key":"10.1016\/bs.irn.2015.05.003_bb0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.irn.2015.05.003_bb0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858410390378","article-title":"Small changes, big impact: Posttranslational modifications and function of huntingtin in Huntington disease","volume":"17","author":"Ehrnhoefer","year":"2011","journal-title":"The Neuroscientist"},{"issue":"5","key":"10.1016\/bs.irn.2015.05.003_bb9040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jms.1409","article-title":"Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: Exemplified in amyotrophic lateral sclerosis biomarker discovery research","volume":"43","author":"Ekegren","year":"2008","journal-title":"Journal of Mass Spectrometry: JMS"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2005.09.004","article-title":"Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling","volume":"21","author":"Emilsson","year":"2006","journal-title":"Neurobiology of Disease"},{"issue":"20","key":"10.1016\/bs.irn.2015.05.003_bb0090","doi-asserted-by":"crossref","first-page":"18320","DOI":"10.1074\/jbc.M110.199448","article-title":"Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein","volume":"286","author":"Fox","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"issue":"21","key":"10.1016\/bs.irn.2015.05.003_bb9035","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1074\/jbc.M112.431957","article-title":"HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation","volume":"288","author":"Gal","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb9080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.wco.0000170951.08924.3d","article-title":"Genetics of Parkinson's disease","volume":"18","author":"Gasser","year":"2005","journal-title":"Current Opinion in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nature Reviews. Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0110","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","article-title":"Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease","volume":"342","author":"Goldknopf","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.irn.2015.05.003_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal Abeta42 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"The American Journal of Pathology"},{"issue":"11","key":"10.1016\/bs.irn.2015.05.003_bb0120","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1021\/pr900474t","article-title":"Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease","volume":"8","author":"Gozal","year":"2009","journal-title":"Journal of Proteome Research"},{"issue":"7","key":"10.1016\/bs.irn.2015.05.003_bb0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.56.7.986","article-title":"Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease","volume":"56","author":"Green","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2015.05.003_bb0130","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/bs.irn.2015.05.003_bb0135","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/13690","article-title":"Quantitative analysis of complex protein mixtures using isotope-coded affinity tags","volume":"17","author":"Gygi","year":"1999","journal-title":"Nature Biotechnology"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.21022","article-title":"Genetics of Parkinson's disease and parkinsonism","volume":"60","author":"Hardy","year":"2006","journal-title":"Annals of Neurology"},{"issue":"12 Pt. 1","key":"10.1016\/bs.irn.2015.05.003_bb0145","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/30.12.1933","article-title":"Two-dimensional electrophoresis and \u201cultrasensitive\u201d silver staining of cerebrospinal fluid proteins in neurological diseases","volume":"30","author":"Harrington","year":"1984","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1016\/bs.irn.2015.05.003_bb0150","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/pr800832s","article-title":"Prion disease diagnosis by proteomic profiling","volume":"8","author":"Herbst","year":"2009","journal-title":"Journal of Proteome Research"},{"issue":"10","key":"10.1016\/bs.irn.2015.05.003_bb0155","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1212\/01.WNL.0000144276.29988.C3","article-title":"Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease","volume":"63","author":"Hochstrasser","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2015.05.003_bb9085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-0404.2002.01301.x","article-title":"Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis","volume":"106","author":"Houi","year":"2002","journal-title":"Acta Neurologica Scandinavica"},{"issue":"6","key":"10.1016\/bs.irn.2015.05.003_bb0160","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Developmental Cell"},{"issue":"Pt. 11","key":"10.1016\/bs.irn.2015.05.003_bb0165","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer's disease","volume":"129","author":"Hye","year":"2006","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb9060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1600-0404.2001.103004255.x","article-title":"Interleukin-1beta converting enzyme\/Caspase-1 (ICE\/Caspase-1) and soluble APO-1\/Fas\/CD 95 receptor in amyotrophic lateral sclerosis patients","volume":"103","author":"I\u0142\u017cecka","year":"2001","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","article-title":"Acetylation targets mutant huntingtin to autophagosomes for degradation","volume":"137","author":"Jeong","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/bi026888g","article-title":"Notch and the amyloid precursor protein are cleaved by similar gamma-secretase(s)","volume":"42","author":"Kimberly","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/bs.irn.2015.05.003_bb0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.imbio.2011.07.024","article-title":"Factor H as a regulator of the classical pathway activation","volume":"217","author":"Kishore","year":"2012","journal-title":"Immunobiology"},{"issue":"5352","key":"10.1016\/bs.irn.2015.05.003_bb0185","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.279.5352.863","article-title":"Impaired locomotion and dopamine signaling in retinoid receptor mutant mice","volume":"279","author":"Krezel","year":"1998","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2015.05.003_bb9055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/prca.201200067","article-title":"Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery","volume":"7","author":"Kr\u00fcger","year":"2013","journal-title":"Proteomics Clinical Applications"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0190","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2015.05.003_bb0195","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ana.410410610","article-title":"Presenilin-1 protein expression in familial and sporadic Alzheimer's disease","volume":"41","author":"Levey","year":"1997","journal-title":"Annals of Neurology"},{"issue":"15","key":"10.1016\/bs.irn.2015.05.003_bb0200","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.jprot.2012.02.032","article-title":"Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease","volume":"75","author":"Licker","year":"2012","journal-title":"Journal of Proteomics"},{"issue":"6","key":"10.1016\/bs.irn.2015.05.003_bb0205","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pmic.201300342","article-title":"Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis","volume":"14","author":"Licker","year":"2014","journal-title":"Proteomics"},{"issue":"12","key":"10.1016\/bs.irn.2015.05.003_bb9025","doi-asserted-by":"crossref","first-page":"e80779","DOI":"10.1371\/journal.pone.0080779","article-title":"Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00002093-199408030-00005","article-title":"Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease","volume":"8","author":"Loeffler","year":"1994","journal-title":"Alzheimer Disease and Associated Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2015.05.003_bb0215","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn983","article-title":"Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha-synuclein","volume":"3","author":"Lotharius","year":"2002","journal-title":"Nature Reviews. Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"38","author":"Motter","year":"1995","journal-title":"Annals of Neurology"},{"issue":"31","key":"10.1016\/bs.irn.2015.05.003_bb0225","doi-asserted-by":"crossref","first-page":"10887","DOI":"10.1073\/pnas.0409283102","article-title":"Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells","volume":"102","author":"Mukai","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2015.05.003_bb0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nature Genetics"},{"issue":"7","key":"10.1016\/bs.irn.2015.05.003_bb0235","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","article-title":"Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease","volume":"14","author":"Mullins","year":"2000","journal-title":"The FASEB Journal"},{"issue":"17","key":"10.1016\/bs.irn.2015.05.003_bb9015","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1111\/febs.12087","article-title":"Understanding ALS: New therapeutic approaches","volume":"280","author":"Musaro","year":"2013","journal-title":"The FEBS Journal"},{"issue":"12","key":"10.1016\/bs.irn.2015.05.003_bb0240","first-page":"1675","article-title":"Macular degeneration and elevated serum ceruloplasmin","volume":"27","author":"Newsome","year":"1986","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"21","key":"10.1016\/bs.irn.2015.05.003_bb9095","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2169\/internalmedicine.47.1278","article-title":"Salivary chromogranin A: Useful and quantitative biochemical marker of affective state in patients with amyotrophic lateral sclerosis","volume":"47","author":"Obayashi","year":"2008","journal-title":"Internal Medicine (Tokyo, Japan)"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0245","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0092-8674(85)90333-2","article-title":"A cellular gene encodes scrapie PrP 27\u201330 protein","volume":"40","author":"Oesch","year":"1985","journal-title":"Cell"},{"issue":"6","key":"10.1016\/bs.irn.2015.05.003_bb9075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1034\/j.1600-0404.2000.90289a.x","article-title":"Decreased plasma levels of fibronectin in amyotrophic lateral sclerosis","volume":"101","author":"Ono","year":"2000","journal-title":"Acta Neurologica Scandinavica"},{"issue":"14","key":"10.1016\/bs.irn.2015.05.003_bb0250","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1523\/JNEUROSCI.19-14-05782.1999","article-title":"alpha-Synuclein shares physical and functional homology with 14-3-3 proteins","volume":"19","author":"Ostrerova","year":"1999","journal-title":"The Journal of Neuroscience"},{"issue":"12","key":"10.1016\/bs.irn.2015.05.003_bb0255","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: A model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0260","doi-asserted-by":"crossref","first-page":"e16032","DOI":"10.1371\/journal.pone.0016032","article-title":"Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease","volume":"6","author":"Perrin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2015.05.003_bb9065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1874205X00802010051","article-title":"Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis","volume":"2","author":"Qureshi","year":"2008","journal-title":"The Open Neurology Journal"},{"issue":"6","key":"10.1016\/bs.irn.2015.05.003_bb9050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/17482960701549681","article-title":"Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects","volume":"8","author":"Ranganathan","year":"2007","journal-title":"Amyotrophic Lateral Sclerosis: Offical Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases"},{"issue":"2","key":"10.1016\/bs.irn.2015.05.003_bb0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0953-816X.2003.03131.x","article-title":"The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin","volume":"19","author":"Rangone","year":"2004","journal-title":"The European Journal of Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2015.05.003_bb0270","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"The American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb9020","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1073\/pnas.92.3.689","article-title":"Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis","volume":"92","author":"Ripps","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2015.05.003_bb0275","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/S0021-9258(18)53661-9","article-title":"Structural alterations in the peptide backbone of \u03b2-amyloid core protein may account for its deposition and stability in Alzheimer's disease","volume":"268","author":"Roher","year":"1993","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/bs.irn.2015.05.003_bb0280","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","article-title":"Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents","volume":"3","author":"Ross","year":"2004","journal-title":"Molecular & Cellular Proteomics"},{"issue":"24","key":"10.1016\/bs.irn.2015.05.003_bb0285","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/elps.201200310","article-title":"Proteomic analysis of prion diseases: Creating clarity or causing confusion?","volume":"33","author":"Rubenstein","year":"2012","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb9045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/mus.21683","article-title":"Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics","volume":"42","author":"Ryberg","year":"2010","journal-title":"Muscle and Nerve"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0290","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1074\/mcp.M114.038018","article-title":"Proteomics analyses for the global proteins in the brain tissues of different human prion diseases","volume":"14","author":"Shi","year":"2015","journal-title":"Molecular & Cellular Proteomics"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-5956-12-5","article-title":"Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics","volume":"12","author":"Song","year":"2014","journal-title":"Proteome Science"},{"issue":"5","key":"10.1016\/bs.irn.2015.05.003_bb0300","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radical Biology & Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0305","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.freeradbiomed.2010.05.016","article-title":"Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism","volume":"49","author":"Sorolla","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb0310","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/biof.1013","article-title":"Protein oxidation in Huntington disease","volume":"38","author":"Sorolla","year":"2012","journal-title":"Biofactors"},{"issue":"6645","key":"10.1016\/bs.irn.2015.05.003_bb0315","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2015.05.003_bb0320","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","article-title":"Apolipoprotein E and Alzheimer disease","volume":"92","author":"Strittmatter","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.irn.2015.05.003_bb0325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-5728(02)00272-2","article-title":"Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain","volume":"131","author":"Strohmeyer","year":"2002","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/bs.irn.2015.05.003_bb0330","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0169-328X(00)00149-2","article-title":"Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain","volume":"81","author":"Strohmeyer","year":"2000","journal-title":"Brain Research. Molecular Brain Research"},{"issue":"2","key":"10.1016\/bs.irn.2015.05.003_bb0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3233\/JAD-2007-11203","article-title":"Proteomics analysis of the Alzheimer's disease hippocampal proteome","volume":"11","author":"Sultana","year":"2007","journal-title":"Journal of Alzheimer's Disease"},{"issue":"16","key":"10.1016\/bs.irn.2015.05.003_bb0340","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/bs.irn.2015.05.003_bb0345","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Archives of Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2015.05.003_bb0350","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","article-title":"IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome","volume":"187","author":"Thompson","year":"2009","journal-title":"The Journal of Cell Biology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2015.05.003_bb0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2005.10.015","article-title":"Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson's disease: A follow-up study","volume":"241","author":"Torsdottir","year":"2006","journal-title":"Journal of the Neurological Sciences"},{"issue":"15","key":"10.1016\/bs.irn.2015.05.003_bb0360","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/jm200605a","article-title":"Important role of oxidative stress biomarkers in Huntington's disease","volume":"54","author":"Tunez","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.irn.2015.05.003_bb0365","doi-asserted-by":"crossref","first-page":"e16266","DOI":"10.1371\/journal.pone.0016266","article-title":"Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease","volume":"6","author":"Twine","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.irn.2015.05.003_bb9090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/17482968.2012.703208","article-title":"TDP-43 plasma levels are higher in amyotrophic lateral sclerosis","volume":"13","author":"Verstraete","year":"2012","journal-title":"Amyotrophic Lateral Sclerosis: Offical Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases"},{"issue":"2","key":"10.1016\/bs.irn.2015.05.003_bb0370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1567205043332225","article-title":"The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease","volume":"1","author":"Vogelgesang","year":"2004","journal-title":"Current Alzheimer Research"},{"issue":"2","key":"10.1016\/bs.irn.2015.05.003_bb0375","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Seminars in Neurology"},{"key":"10.1016\/bs.irn.2015.05.003_bb0380","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s004010051190","article-title":"Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly","volume":"100","author":"Walker","year":"2000","journal-title":"Acta Neuropathologica"},{"issue":"15","key":"10.1016\/bs.irn.2015.05.003_bb0385","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","article-title":"Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus","volume":"17","author":"Warby","year":"2008","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.irn.2015.05.003_bb0390","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-5956-6-8","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"6","author":"Werner","year":"2008","journal-title":"Proteome Science"},{"issue":"6","key":"10.1016\/bs.irn.2015.05.003_bb0395","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nn1702","article-title":"Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function","volume":"9","author":"Yanai","year":"2006","journal-title":"Nature Neuroscience"},{"issue":"5310","key":"10.1016\/bs.irn.2015.05.003_bb0400","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.276.5310.248","article-title":"Dopamine neuron agenesis in Nurr1-deficient mice","volume":"276","author":"Zetterstrom","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0405","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/nbdi.2000.0319","article-title":"Oxidative stress and genetics in the pathogenesis of Parkinson's disease","volume":"7","author":"Zhang","year":"2000","journal-title":"Neurobiology of Disease"},{"issue":"10","key":"10.1016\/bs.irn.2015.05.003_bb0410","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/NEN.0b013e318187a832","article-title":"Proteomics of human neurodegenerative diseases","volume":"67","author":"Zhang","year":"2008","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2015.05.003_bb0415","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1309\/W01Y0B808EMEH12L","article-title":"CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases","volume":"129","author":"Zhang","year":"2008","journal-title":"American Journal of Clinical Pathology"}],"container-title":["International Review of Neurobiology","Omic Studies of Neurodegenerative Disease: Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T08:58:31Z","timestamp":1652518711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774215000197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128014806"],"references-count":101,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2015.05.003","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}